Perspective · 3 Nov 2025
Short communicationPublished 2018
Possibility of the Strategic Treatment for Various Tumors using the Leukotriene Receptor Antagonist: Discussion Based on the Common Pathologic Findings that Mast Cells and Leukotrienes are Involved in the Development and Proliferation of Tumors
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The leukotriene receptor antagonist is indicated with a therapeutic drug of asthma and is one of the antiallergicagents. We found that mast cells and a leukotriene receptor commonly emerged for various malignant and benigntumors and proved that the allergic reaction was strongly associated with development and proliferation of tumors.And we experimented on the effect of treatment of the leukotriene receptor antagonist for spontaneous rat tumor andconfirmed the efficacy. Our data show a wide effect of this medicine and the fewer side effects and will cause adiscussion for the chemotherapy of the current malignant tumor. This commentary briefly summarizes about currentevidence and future prospect in the oncotherapy of the leukotriene receptor antagonist.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Chemotherapy: Open Access.
Opinion · 3 Nov 2025
Evaluation of Surgical Radiotherapy and Chemotherapy in the Treatment of Gynaecological Malignancies
Research article · 18 Aug 2025
Response Evaluation to Oxaliplatin-Based Adjuvant Chemotherapy after Curative Resection between Right and Left-Sided Stage II and III Colon Cancer: A Retrospective Survival Analysis
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalChemotherapy: Open Access
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Masao Sugamata”
